Marianne Sarrazin is a partner in the firm’s Life Sciences group. With a focus on the biotech and medtech industries, she regularly advises such companies on going public — via traditional IPO or alternative path to public (reverse merger or deSPAC). Ms. Sarrazin also frequently serves as outside general counsel to her public company clients, closely advising management teams and boards of directors on a wide variety of matters, including ongoing SEC reporting and US securities law requirements, as well as Nasdaq/NYSE compliance and other corporate governance matters, including recent diversity initiatives. She also routinely represents clients — both US and foreign private issuers — in public and private capital markets transactions including follow-on offerings, at-the-market offerings and PIPEs.
Areas of Practice
TÄTIGKEITSFELDER
Domaines D’Expertise
业务范围

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Recent Life Sciences Transactions

  • Advised a clinical stage biotechnology company on its proposed initial public offering*
  • Advised a Nasdaq-listed clinical stage biopharmaceutical ophthalmic company on its $40 million “at-the-market” offering program*
  • Advised a Nasdaq-listed clinical stage biopharmaceutical ophthalmic company on its $35 million follow-on offering and $3 million concurrent private placement*
  • Advised a Nasdaq-listed clinical stage genomic medicine company on its $150 million “at-the-market” offering program*
  • Advised a Nasdaq-listed clinical stage biopharmaceutical company on its reverse merger with a private company
  • Advised a Nasdaq-listed clinical stage biopharmaceutical ophthalmic company on its $10 million follow-on offering and concurrent private placement*
  • Advised a Nasdaq-listed Swiss clinical stage biopharmaceutical company on its $18 million follow-on offering*
  • Advised a Nasdaq-listed Canadian clinical stage biopharmaceutical company on its $45 million follow-on offering*
  • Advised a Nasdaq-listed Canadian clinical stage biopharmaceutical company on its $25 million private placement
  • Advised a Nasdaq-listed clinical stage immunology company on a $250 million private placement concurrent with a license agreement
  • Advised a Nasdaq-listed genomic medicine company on its $225 million private placement concurrent with a license agreement

Recent SPAC/deSPAC Transactions

  • Advised a cellular therapeutic company in its pending business combination with a Nasdaq-listed SPAC and concurrent PIPE*
  • Advised a private digital auto insurance platform company on its initial business combination with a Nasdaq-listed SPAC and concurrent PIPE*
  • Advised a SPAC on its $80 million initial public offering*
  • Advised an electric vehicle company on its SEC reporting and other obligations post-business combination with a Nasdaq-listed SPAC*
  • Advised an electric vehicle company on its SEC reporting and other obligations post-business combination with a NYSE-listed SPAC*

*Denotes experience prior to joining Goodwin.

Professional Experience
Prior to joining Goodwin, Ms. Sarrazin was most recently a Special Counsel at Cooley LLP. Prior to Cooley, she was Special Counsel at Reed Smith LLP. Ms. Sarrazin began her career at Cleary Gottlieb Steen & Hamilton.

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 1999
Georgetown University Law Center
(cum laude)
B.A., French and Political Science, 1993
University of Arizona
(cum laude)

Admissions

Bar

California
New York

Languages

Sprachen

LANGUES

语言

English
French
Profile Image
Get In Touch
Kontakt
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师